Showing results (1831-1840 of 2,455) with videos related to

Sort By:
Pageof 246
Cell Reports|November 29, 2018
Somatic Mutations Reveal Lineage Relationships and Age-Related Mutagenesis in Human HematopoiesisFernando G Osorio, Axel Rosendahl Huber, Rurika Oka, et al.
Clinical Pharmacology and Therapeutics|November 1, 1994
The pharmacokinetic-pharmacodynamic (Digit Symbol Substitution Test) relationship of flumazenil in a midazolam steady-state model in healthy volunteersJ Zhi, J W Massarella, A T Melia, et al.
Orthopaedic Journal of Sports Medicine|June 19, 2025
Defining Clinically Meaningful Subgroups in Patients Undergoing Arthroscopic Rotator Cuff Repair Using Unsupervised Machine LearningYining Lu, Elyse J Berlinberg, Kareme Alder, et al.
Arxiv|April 1, 2025
Critical review of patient outcome study in head and neck cancer radiotherapyJingyuan Chen, Yunze Yang, Chenbin Liu, et al.
Respiratory Medicine|September 14, 2019
No stone unturned: Nodule Net, an intervention to reduce loss to follow-up of lung nodulesT G Weinstock, A Tewari, H Patel, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 6, 2012
Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysisSarah B Fisher, Sameer H Patel, David A Kooby, et al.
Nature|July 16, 2025
Prophages block cell surface receptors to preserve their viral progenyVéronique L Taylor, Pramalkumar H Patel, Megha Shah, et al.
The Journal of Urology|February 9, 2026
Results from the ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) Randomized Controlled TrialMichael E Rezaee, Michelle I Higgins, Zhuo Tony Su, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 10, 2023
Defining the operative time threshold for safety in patients undergoing robotic pancreaticoduodenectomyAaron M Delman, Jenna N Whitrock, Kevin M Turner, et al.
The Journal of Urology|June 22, 2026
Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin (BCG)‒Naïve Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year OutcomesTyler S Garman, Soum Lokeshwar, Jack Campbell, et al.
Pageof 246